DOCSLIB.ORG

Subjectindex

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Subjectindex J Neurol Neurosurg Psychiatry 2002;73:e4(http://www.jnnp.com/cgi/content/full/73/6/e4) 1 of 10 J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.73.6.e4 on 1 December 2002. Downloaded from Subject index ................................................................................. 14-3-3 protein, Hashimoto’s encephalopathy mimicking antibodies, Myopathy with antibodies to the signal recognition Creutzfeldt-Jakob disease: brain biopsy findings, 601 particle: clinical and pathological features, 420 anticholinergic, Drugs for Parkinson’s disease, 607 22q11 deletion, Myoclonic movement disorder associated with anticoagulation, Radiology of stroke, 96 microdeletion of chromosome 22q11, 600 Transoesophageal echocardiography in selecting patients for α synuclein Meta-analysis of α synuclein/ NACP polymorphism in anticoagulation after ischaemic stroke or transient ischaemic Parkinson’s disease in Japan, 350 attack, 29 acalculia, Intraoperative mapping of the cortical areas involved in antiepileptic drugs, Reproductive dysfunction in women with multiplication and subtraction: an electrostimulation study in a epilepsy: recommendations for evaluation and management, patient with a left parietal glioma, 733 121 acromegaly, Pituitary tumours and acromegaly (Pierre Marie’s apolipoprotein E, The apolipoprotein E e2 allele and decline in epi- disease), 394 sodic memory, 672 acute dopaminergic challenge test, Acute dopaminergic apomorphine, Drugs for Parkinson’s disease, 607 challenge tests to assess postural/kinetic tremor of different appetite, Changes in appetite, food preference, and eating habits in origin: a case report, 206 frontotemporal dementia and Alzheimer’s disease, 371 acute head injury, Acute head injury for the neurologist, i3 aqueductal stenosis, Festination as the leading symptom of late Acute head injury for the neurologist, ii3 onset idiopathic aqueductal stenosis, 599 acute transverse myelitis, Bladder dysfunction in acute transverse arterial aneurysms, Concurrent arterial aneurysms in brain arterio- myelitis: magnetic resonance imaging and neurophysiological venous malformations with haemorrhagic presentation, 294 and urodynamic correlations, 154 assessment, Sensitivity of clinical and behavioural tests of spatial adhesion molecules, High concentrations of sVCAM-1 and neglect after right hemisphere stroke, 160 sICAM-1 in the cerebrospinal fluid of patients with intracerebral association study, Genetic variability in the insulin signalling path- haemorrhage are associated with poor outcome, 346 way may contribute to the risk of late onset Alzheimer’s affective disorder, Enduring increased risk of developing disease, 261 depression and mania in patients with dementia, 40 ataxia, Acute attacks and brain stem signs in a patient with glutamic akinetic mutism, Distinct neuropsychological characteristics in acid decarboxylase autoantibodies, 345 Creutzfeldt-Jakob disease, 686 atlanto-axial instability, Fatal instability following “odontoid alcohol drinking, Chronic alcohol use and first symptomatic sparing” transoral decompression of a periodontoid epileptic seizures, 495 pseudotumour, 756 alcoholism, Chronic alcohol use and first symptomatic epileptic auditory cortex, Electrophysiological evidence for a defect in the seizures, 495 processing of temporal sound patterns in multiple sclerosis, alien hand syndrome, Posterior alien hand syndrome after a right 561 thalamic infarct, 447 auditory evoked potential, Electrophysiological evidence for a Alzheimer’s dementia, We are how we eat?, 358 defect in the processing of temporal sound patterns in multiple Alzheimer’s disease, Alterations in brain activation during sclerosis, 561 cholinergic enhancement with rivastigmine in Alzheimer’s autoantibodies, Neuromyotonia and myasthenia gravis without disease, 665 thymoma, 344 β Association study of three polymorphisms of TGF- 1 gene with automatic voluntary dissociation, Slowly progressive Alzheimer’s disease, 62 Foix–Chavany–Marie syndrome associated with chronic herpes Changes in appetite, food preference, and eating habits in fronto- simplex encephalitis, 203 temporal dementia and Alzheimer’s disease, 371 autonomic dysfunction, Progressive sudomotor dysfunction in Detection of grey matter loss in mild Alzheimer’s disease with amyotrophic lateral sclerosis, 68 voxel based morphometry, 657 autonomic, High blood pressure and decreased heart rate variabil- Differentiation of dementia with Lewy bodies from Alzheimer’s ity in the Cuban epidemic neuropathy, 71 disease using a dopaminergic presynaptic ligand, 134 axonal neuropathy, Six novel connexin32 (GJB1) mutations in Genetic variability in the insulin signalling pathway may contribute X-linked Charcot-Marie-Tooth disease, 304 to the risk of late onset Alzheimer’s disease, 261 Goal setting and attainment in Alzheimer’s disease patients Babinski sign, The Babinski sign, 360 treated with donepezil, 500 bacterial meningitis, Increased serum concentrations of tissue http://jnnp.bmj.com/ Hippocampal atrophy and neocortical dysfunction in early plasminogen activator correlate with an adverse clinical Alzheimer’s disease, 470 outcome in patients with bacterial meningitis, 456 Meaningful treatment outcomes in Alzheimer’s disease, 471 basilar artery, Endovascular coiling versus neurosurgical clipping Morphometry of the corpus callosum in patients with questionable in patients with a ruptured basilar tip aneurysm, 591 and mild dementia, 59 bed rest, Effectiveness of bed rest after mild traumatic brain injury: Phosphorylated tau in cerebrospinal fluid as a marker for a randomised trial of no versus six days of bed rest, 167 Creutzfeldt–Jakob disease, 79 Behçet’s disease, An unusual case of Behçet’s disease presenting Relation between medial temporal atrophy and functional brain with bilateral internal carotid artery occlusion, 343 activity during memory processing in Alzheimer’s disease: a combined MRI and SPECT study, 508 bladder dysfunction, Bladder dysfunction in acute transverse Visual association test to detect early dementia of the Alzheimer myelitis: magnetic resonance imaging and neurophysiological on October 5, 2021 by guest. Protected copyright. type, 126 and urodynamic correlations , 154 amantadine, Drugs for Parkinson’s disease, 607 BOLD, Increase in focal concentration of deoxyhaemoglobin during amnesia, Visual association test to detect early dementia of the neuronal activity in cerebral ischaemic patients, 182 Alzheimer type, 126 Botox, Dysport produces intrinsically more swallowing problems amygdala, Measurement of amygdala T2 relaxation time in than Botox: unexpected results from a conversion factor study temporal lobe epilepsy, 753 in cervical dystonia, 604 amyloid β protein, Association study of three polymorphisms of brachial plexus, Inflammation and neuropathic attacks in TGF-β1 gene with Alzheimer’s disease, 62 hereditary brachial plexus neuropathy, 45 amyloid neuropathy, “Sporadic” familial amyloidotic polyneuropa- brain atrophy, Intracranial cerebrospinal fluid measurement studies thy in a German patient with B cell lymphocytic leukaemia, 86 in suspected idiopathic normal pressure hydrocephalus, amyotrophic lateral sclerosis, Progressive sudomotor dysfunction secondary normal pressure hydrocephalus, and brain atrophy, in amyotrophic lateral sclerosis, 68 552 aneurysm, Aneurysm of the extracranial internal carotid artery brain biopsy, Hashimoto’s encephalopathy mimicking Creutzfeldt- presenting as the syndrome of glossopharyngeal pain and Jakob disease: brain biopsy findings, 601 syncope, 87 brain damage, Neck muscle vibration induces lasting recovery in Endovascular coiling versus neurosurgical clipping in patients spatial neglect, 412 with a ruptured basilar tip aneurysm, 591 brain dysfunction, Hippocampal atrophy and neocortical dysfunc- Thunderclap headache, reversible cerebral arterial vasoconstric- tion in early Alzheimer’s disease, 470 tion, and unruptured aneurysms, 96 brain ischaemia, Acute hyperperfusion syndrome complicating angiography, Feasibility and validity of transcranial duplex sonog- EC-IC bypass, 88 raphy in patients with acute stroke, 17 brain stem, Acute attacks and brain stem signs in a patient with angular gyrus, Intraoperative mapping of the cortical areas glutamic acid decarboxylase autoantibodies, 345 involved in multiplication and subtraction: an electrostimulation Cognitive dysfunction after isolated brain stem insult. An study in a patient with a left parietal glioma, 733 underdiagnosed cause of long term morbidity, 191 www.jnnp.com 2of10 Subject index J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.73.6.e4 on 1 December 2002. Downloaded from brain, Demyelination in the brain as a paraneoplastic disorder: can- Increased serum concentrations of tissue plasminogen activator didates include some cases of seminoma and central nervous correlate with an adverse clinical outcome in patients with bac- system lymphoma, 352 terial meningitis, 456 brainstem, MRI findings in mesenrhombencephalitis due to Listeria cerebrovascular disease, Executive dysfunction and depressive monocytogenes, 775 symptoms in cerebrovascular disease, 462 Neurological presentation of Fabry’s disease in a 52 year old cabergoline, Long term tolerability of high dose ergoline derived man, 340 dopamine agonist therapy for the treatment of Parkinson’s cerebrovascular events, Patent foramen ovale, cerebrovascular disease, 602 risk, and complement, 351 CAG/polyglutamine, Paradoxical absence of nuclear inclusion in certification, Certification of deaths
Load more

Recommended publications
  • Mitochondrial Trnaleu(Uur) May Cause an MERRF Syndrome
    J7ournal ofNeurology, Neurosurgery, and Psychiatry 1996;61:47-51 47 The A to G transition at nt 3243 of the J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.61.1.47 on 1 July 1996. Downloaded from mitochondrial tRNALeu(uuR) may cause an MERRF syndrome Gian Maria Fabrizi, Elena Cardaioli, Gaetano Salvatore Grieco, Tiziana Cavallaro, Alessandro Malandrini, Letizia Manneschi, Maria Teresa Dotti, Antonio Federico, Giancarlo Guazzi Abstract Two distinct maternally inherited encephalo- Objective-To verify the phenotype to myopathies with ragged red fibres have been genotype correlations of mitochondrial recognised on clinical grounds: MERRF, DNA (mtDNA) related disorders in an which is characterised by myoclonic epilepsy, atypical maternally inherited encephalo- skeletal myopathy, neural deafness, and optic myopathy. atrophy,' and MELAS, which is defined by Methods-Neuroradiological, morpholog- stroke-like episodes in young age, episodic ical, biochemical, and molecular genetic headache and vomiting, seizures, dementia, analyses were performed on the affected lactic acidosis, skeletal myopathy, and short members of a pedigree harbouring the stature.2 Molecular genetic studies later con- heteroplasmic A to G transition at firmed the nosological distinction between the nucleotide 3243 of the mitochondrial two disorders, showing that MERRF is strictly tRNAI-u(UR), which is usually associated associated with two mutations of the mito- with the syndrome of mitochondrial chondrial tRNALYs at nucleotides 83443 and encephalomyopathy, lactic
    [Show full text]
  • When Should MELAS (Mitochondrial Myopathy, Encephalopathy, Lactic
    DOI: 10.1590/0004-282X20150154 VIEW ANDARTICLE REVIEW When should MELAS (Mitochondrial myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like episodes) be the diagnosis? Quando o diagnóstico deveria ser MELAS (Miopatia mitocondrial, encefalopatia, acidose lática, e episódios semelhantes a acidente vascular cerebral)? Paulo José Lorenzoni, Lineu Cesar Werneck, Cláudia Suemi Kamoi Kay, Carlos Eduardo Soares Silvado, Rosana Herminia Scola ABSTRACT Mitochondrial myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like episodes (MELAS) is a rare mitochondrial disorder. Diagnostic criteria for MELAS include typical manifestations of the disease: stroke-like episodes, encephalopathy, evidence of mitochondrial dysfunction (laboratorial or histological) and known mitochondrial DNA gene mutations. Clinical features of MELAS are not necessarily uniform in the early stages of the disease, and correlations between clinical manifestations and physiopathology have not been fully elucidated. It is estimated that point mutations in the tRNALeu(UUR) gene of the DNAmt, mainly A3243G, are responsible for more of 80% of MELAS cases. Morphological changes seen upon muscle biopsy in MELAS include a substantive proportion of ragged red fibers (RRF) and the presence of vessels with a strong reaction for succinate dehydrogenase. In this review, we discuss mainly diagnostic criterion, clinical and laboratory manifestations, brain images, histology and molecular findings as well as some differential diagnoses and current treatments. Keywords: MELAS, mitochondria, myopathy, stroke, encephalopathy, genetics. RESUMO Miopatia mitocondrial, encefalopatia, acidose lática, e episódios semelhantes a acidente vascular cerebral (MELAS) é uma rara doença mitocondrial. Os critérios diagnósticos para MELAS incluem as manifestações típicas da doença: episódios semelhantes a acidente vascular cerebral, encefalopatia, evidência de disfunção mitocondrial (laboratorial ou histológica) e mutação conhecida em genes do DNA mitocondrial.
    [Show full text]
  • Neurosurgery
    KALEIDA HEALTH Name ____________________________________ Date _____________ DELINEATION OF PRIVILEGES - NEUROSURGERY All members of the Department of Neurosurgery at Kaleida Health must have the following credentials: 1. Successful completion of an ACGME accredited Residency, Royal College of Physicians and Surgeons of Canada, or an ACGME equivalent Neurosurgery Residency Program. 2. Members of the clinical service of Neurosurgery must, within five (5) years of appointment to staff, achieve board certification in Neurosurgery. *Maintenance of board certification is mandatory for all providers who have achieved this status* Level 1 (core) privileges are those able to be performed after successful completion of an accredited Neurosurgery Residency program. The removal or restriction of these privileges would require further investigation as to the individual’s overall ability to practice, but there is no need to delineate these privileges individually. PLEASE NOTE: Please check the box for each privilege requested. Do not use an arrow or line to make selections. We will return applications that ignore this directive. LEVEL I (CORE) PRIVILEGES Basic Procedures including: Admission and Follow-Up Repair cranial or dural defect or lesion History and Physical for diagnosis and treatment plan* Seizure Chest tube placement Sterotactic framed localization of lesion Debride wound Sterotactic frameless localization Endotracheal intubation Transsphenoidal surgery of pituitary lesion Excision of foreign body Trauma Insertion of percutaneous arterial
    [Show full text]
  • Hydrocephalus and Shunts
    Hydrocephalus and Shunts Information for patients 2 What is hydrocephalus? The brain is surrounded by fluid, called CSF - Cerebrospinal fluid. The CSF provides some protection for the brain. The brain makes CSF in special fluid-filled spaces called ventricles. The ventricles link to each other by a system of channels through which the CSF flows and eventually leaves to surround the whole brain and spinal cord. The CSF is then taken back into the blood-stream by special channels beside the major veins on the inside of the skull. These are called arachnoid granulations. Figure 1 - Diagram of the brain showing normal CSF pathways 3 Hydrocephalus is a condition in which the CSF builds up within the brain. There are a number of causes of this: 1. The fluid pathways may be blocked or narrowed so that fluid cannot flow adequately. The causes of this blockage can include scarring, a variation in the development of the fluid pathways (present from birth) or sometimes by a tumour which blocks the CSF flow. 2. Sometimes the fluid collection channels (arachnoid granulations) can become blocked and stop working - in a similar manner to how leaves can block a drain. This can happen following an infection or a bleed (haemorrhage). As a result of this block in fluid flow, CSF builds up inside the brain, resulting in an increase in pressure. As a result of this patients most commonly report symptoms of headaches, nausea and vomiting, but problems with balance and short term memory have also been reported. There is another group of patients who do not fit into the patterns described above.
    [Show full text]
  • Congenital Disorders of Glycosylation from a Neurological Perspective
    brain sciences Review Congenital Disorders of Glycosylation from a Neurological Perspective Justyna Paprocka 1,* , Aleksandra Jezela-Stanek 2 , Anna Tylki-Szyma´nska 3 and Stephanie Grunewald 4 1 Department of Pediatric Neurology, Faculty of Medical Science in Katowice, Medical University of Silesia, 40-752 Katowice, Poland 2 Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland; [email protected] 3 Department of Pediatrics, Nutrition and Metabolic Diseases, The Children’s Memorial Health Institute, W 04-730 Warsaw, Poland; [email protected] 4 NIHR Biomedical Research Center (BRC), Metabolic Unit, Great Ormond Street Hospital and Institute of Child Health, University College London, London SE1 9RT, UK; [email protected] * Correspondence: [email protected]; Tel.: +48-606-415-888 Abstract: Most plasma proteins, cell membrane proteins and other proteins are glycoproteins with sugar chains attached to the polypeptide-glycans. Glycosylation is the main element of the post- translational transformation of most human proteins. Since glycosylation processes are necessary for many different biological processes, patients present a diverse spectrum of phenotypes and severity of symptoms. The most frequently observed neurological symptoms in congenital disorders of glycosylation (CDG) are: epilepsy, intellectual disability, myopathies, neuropathies and stroke-like episodes. Epilepsy is seen in many CDG subtypes and particularly present in the case of mutations
    [Show full text]
  • A Systematic Review of Virtual Reality for the Assessment of Technical Skills in Neurosurgery
    NEUROSURGICAL FOCUS Neurosurg Focus 51 (2):E15, 2021 A systematic review of virtual reality for the assessment of technical skills in neurosurgery *Justin Chan, BS,1 Dhiraj J. Pangal, BS,1 Tyler Cardinal, BS,1 Guillaume Kugener, MEng,1 Yichao Zhu, MS,1 Arman Roshannai,1 Nicholas Markarian, BS,1 Aditya Sinha, BS,1 Anima Anandkumar, PhD,2 Andrew Hung, MD,3 Gabriel Zada, MD, MS,1 and Daniel A. Donoho, MD4 1USC Department of Neurosurgery, Keck School of Medicine of the University of Southern California, Los Angeles, California; 2Computing + Mathematical Sciences, California Institute of Technology, Pasadena, California; 3USC Department of Urology, Keck School of Medicine of the University of Southern California, Los Angeles, California; and 4Texas Children’s Hospital, Baylor College of Medicine, Houston, Texas OBJECTIVE Virtual reality (VR) and augmented reality (AR) systems are increasingly available to neurosurgeons. These systems may provide opportunities for technical rehearsal and assessments of surgeon performance. The assessment of neurosurgeon skill in VR and AR environments and the validity of VR and AR feedback has not been systematically reviewed. METHODS A systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines was conducted through MEDLINE and PubMed. Studies published in English between January 1990 and February 2021 describing the use of VR or AR to quantify surgical technical performance of neurosurgeons without the use of human raters were included. The types and categories of automated performance metrics (APMs) from each of these studies were recorded. RESULTS Thirty-three VR studies were included in the review; no AR studies met inclusion criteria.
    [Show full text]
  • CSW Dysnatremia Pathway
    Dysnatremia v2.2: Table of Contents Approval & Citation Summary of Version Changes Explanation of Evidence Ratings Patients At Risk for High or Low Sodium Postop Neurosurgery At Risk for Hyponatremia Periop Neurosurgery At Risk for Diabetes Insipidus Postop Neurosurgery At Risk for Diabetes Insipidus Patients with Diabetes Insipidus Periop Known Diabetes Insipidus ED or Acute Care Known Diabetes Insipidus Background How Dysnatremia Occurs For questions concerning this pathway, Last Updated: May 2021 contact: [email protected] Next Expected Review: October 2023 © 2021 Seattle Children’s Hospital, all rights reserved, Medical Disclaimer Dysnatremia v2.2: Postop Neurosurgery At Risk for Hyponatremia Approval & Citation Summary of Version Changes Explanation of Evidence Ratings Return to Table of Contents Monitoring Procedures at High Risk Orders for Low Sodium • Serum sodium and serum osmolality qam x 3 days Inclusion Criteria • Daily weight • Craniotomy • Patients with procedure • Strict intake and output • Craniosynostosis repair/ at high risk for low • If no void over 8 hours, bladder scan or ask patient to cranial vault expansion/frontal sodium void orbital advancement Call Contact Provider for • Hemispherectomy/lobectomy Exclusion Criteria • Placement of Grid and strip • Sodium <135 • Age <1 year • Tumor resection/biopsy • Endoscopic 3rd ventriculostomy • Intake and output positive > 40 ml/kg over 8 hours (ETV) • Insertion of lumbar drain • Urine output <0.5 ml/kg/hr or no void over 8 hours • Laser ablation • Subgaleal
    [Show full text]
  • Hereditary Muscle Diseases and the Heart: the Cardiologist's Perspective
    European Heart Journal Supplements (2020) 22 (Supplement E), E13–E19 The Heart of the Matter doi:10.1093/eurheartj/suaa051 Hereditary muscle diseases and the heart: the cardiologist’s perspective Lorenzo Giuliani1, Alessandro Di Toro1, Mario Urtis1, Alexandra Smirnova1, Monica Concardi1, Valentina Favalli2, Alessandra Serio1, Maurizia Grasso1, and Eloisa Arbustini1* 1Centre for Inherited Cardiovascular Diseases, IRCCS Foundation University Hospital Policlinico San Matteo, Pavia, Italy; and 2Ingenomics Srls, Polo Tecnologico, Pavia, Italy KEYWORDS Hereditary muscle disease; Cardiomyopathy; Heart failure Introduction patients in a way to collect data useful in accelerating tar- geted treatment development. Cardiac manifestations in hereditary muscle diseases in- clude cardiomyopathies, defects of cardiac conductions Dilated and hypokinetic phenotypes (DCM) with or without primary myocardial muscle involvement, 1,2 and arrhythmias. Symptoms and signs of these diseases The most common heritable muscle diseases affecting the 3 may exhibit in paediatric as well as in adult age, and in heart and leading to dilated and hypokinetic cardiac phe- many cases only a multidisciplinary clinical approach can notype include dystrophinopathies, limb girdle muscular 4,5 ensure correct diagnosis and management. Cardiologists dystrophies (LGMD), and Emery–Dreifuss Muscular might be the first to recognize an apparently lone cardiac Dystrophies (EDMD). involvement as an important clinical marker of an heredi- tary muscle disease or be the first in line in a multidiscipli- nary team when cardiac involvement represents the major Dystrophinopathies clinical manifestation affecting evolution and prognosis of Mutations in the DMD gene encoding for dystrophin cause the disease.6 dystrophinopathies, a group of rare X-linked recessive The actual classifications of hereditary muscle disorders (XLR) muscle diseases.
    [Show full text]
  • Orphanet Report Series Rare Diseases Collection
    Marche des Maladies Rares – Alliance Maladies Rares Orphanet Report Series Rare Diseases collection DecemberOctober 2013 2009 List of rare diseases and synonyms Listed in alphabetical order www.orpha.net 20102206 Rare diseases listed in alphabetical order ORPHA ORPHA ORPHA Disease name Disease name Disease name Number Number Number 289157 1-alpha-hydroxylase deficiency 309127 3-hydroxyacyl-CoA dehydrogenase 228384 5q14.3 microdeletion syndrome deficiency 293948 1p21.3 microdeletion syndrome 314655 5q31.3 microdeletion syndrome 939 3-hydroxyisobutyric aciduria 1606 1p36 deletion syndrome 228415 5q35 microduplication syndrome 2616 3M syndrome 250989 1q21.1 microdeletion syndrome 96125 6p subtelomeric deletion syndrome 2616 3-M syndrome 250994 1q21.1 microduplication syndrome 251046 6p22 microdeletion syndrome 293843 3MC syndrome 250999 1q41q42 microdeletion syndrome 96125 6p25 microdeletion syndrome 6 3-methylcrotonylglycinuria 250999 1q41-q42 microdeletion syndrome 99135 6-phosphogluconate dehydrogenase 67046 3-methylglutaconic aciduria type 1 deficiency 238769 1q44 microdeletion syndrome 111 3-methylglutaconic aciduria type 2 13 6-pyruvoyl-tetrahydropterin synthase 976 2,8 dihydroxyadenine urolithiasis deficiency 67047 3-methylglutaconic aciduria type 3 869 2A syndrome 75857 6q terminal deletion 67048 3-methylglutaconic aciduria type 4 79154 2-aminoadipic 2-oxoadipic aciduria 171829 6q16 deletion syndrome 66634 3-methylglutaconic aciduria type 5 19 2-hydroxyglutaric acidemia 251056 6q25 microdeletion syndrome 352328 3-methylglutaconic
    [Show full text]
  • Haematological Abnormalities in Mitochondrial Disorders
    Singapore Med J 2015; 56(7): 412-419 Original Article doi: 10.11622/smedj.2015112 Haematological abnormalities in mitochondrial disorders Josef Finsterer1, MD, PhD, Marlies Frank2, MD INTRODUCTION This study aimed to assess the kind of haematological abnormalities that are present in patients with mitochondrial disorders (MIDs) and the frequency of their occurrence. METHODS The blood cell counts of a cohort of patients with syndromic and non-syndromic MIDs were retrospectively reviewed. MIDs were classified as ‘definite’, ‘probable’ or ‘possible’ according to clinical presentation, instrumental findings, immunohistological findings on muscle biopsy, biochemical abnormalities of the respiratory chain and/or the results of genetic studies. Patients who had medical conditions other than MID that account for the haematological abnormalities were excluded. RESULTS A total of 46 patients (‘definite’ = 5; ‘probable’ = 9; ‘possible’ = 32) had haematological abnormalities attributable to MIDs. The most frequent haematological abnormality in patients with MIDs was anaemia. 27 patients had anaemia as their sole haematological problem. Anaemia was associated with thrombopenia (n = 4), thrombocytosis (n = 2), leucopenia (n = 2), and eosinophilia (n = 1). Anaemia was hypochromic and normocytic in 27 patients, hypochromic and microcytic in six patients, hyperchromic and macrocytic in two patients, and normochromic and microcytic in one patient. Among the 46 patients with a mitochondrial haematological abnormality, 78.3% had anaemia, 13.0% had thrombopenia, 8.7% had leucopenia and 8.7% had eosinophilia, alone or in combination with other haematological abnormalities. CONCLUSION MID should be considered if a patient’s abnormal blood cell counts (particularly those associated with anaemia, thrombopenia, leucopenia or eosinophilia) cannot be explained by established causes.
    [Show full text]
  • Clinical Exome Sequencing for Genetic Identification of Rare Mendelian Disorders
    Supplementary Online Content Lee H, Deignan JL, Dorrani N, Strom SP, Kantarci S, Quintero-Rivera F, et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA. doi:10.1001/jama.2014.14604. eMethods 1. Sample acquisition and pre-test sample processing eMethods 2. Exome capture and sequencing eMethods 3. Sequence data analysis eMethods 4. Variant filtration and interpretation eMethods 5. Determination of variant pathogenicity eFigure 1. UCLA Clinical Exome Sequencing (CES) workflow eFigure 2. Variant filtration workflow starting with ~21K variants across the exome and comparing the mean number of variants observed from trio-CES versus proband-CES eFigure 3. Variant classification workflow for the variants found within the primary genelist (PGL) eTable 1. Metrics used to determine the adequate quality of the sequencing test for each sample eTable 2. List of molecular diagnoses made eTable 3. List of copy number variants (CNVs) and uniparental disomy (UPD) reported and confirmatory status eTable 4. Demographic summary of 814 cases eTable 5. Molecular Diagnosis Rate of Phenotypic Subgroups by Age Group for Other Clinical Exome Sequencing References © 2014 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 10/01/2021 This supplementary material has been provided by the authors to give readers additional information about their work. © 2014 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 10/01/2021 eMethods 1. Sample acquisition and pre-test sample processing. Once determined by the ordering physician that the patient's presentation is clinically appropriate for CES, patients were offered the test after a counseling session ("pre-test counseling") [eFigure 1].
    [Show full text]
  • Aesculap® Neuroendoscopy
    Aesculap® Neuroendoscopy Intraventricular, Endoscope-Assisted, Transnasal/Transsphenoidal Neuroendoscopic Equipment With comments from international experts in the field of neuroendoscopy and minimally-invasive neurosurgery. Aesculap Neurosurgery Aesculap Neuroendoscopy Michael Fritsch Jeremy Greenlee André Grotenhuis Nikolai Hopf Neubrandenburg, Germany Iowa City, USA Nijmegen, Netherlands Stuttgart, Germany 2 Aesculap Neurosurgery Intraventricular „ In 1924, the famous general and neurological achieve deep seated regions without approach surgeon William Halsted expressed his belief “… related traumatization of sensitive neurovascular that the tendency will always be in the direction structures. of exercising greater care and refinement in oper- The endoscopic image allows illumination and ating”. Today, within the third millennium this fun- inspection of angles in hidden parts of the surgical damental philosophy of minimally invasive therapy field with the and clear depiction of anatomical should be emphasized more than ever before, details. In addition, due to the enormous optical operating with a minimum of iatrogenic trauma depth of field of modern endoscopes, endoscopes while achieving maximum surgical efficiency. provide a three dimensional aspect of anatomic Recent improvements in preoperative imaging and structures. Recently, the intraoperative use of full surgical instrumentation allow neurosurgeons to high definition (HD) image quality offers a new treat more complex pathologies through custom- area in endoscopic neurosurgery
    [Show full text]